Upload File

genetic and epigenetic silencing of microrna-203 enhances abl1 and bcr-abl1 oncogene expression...

  • Home
  • Documents
  • Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression María J. Bueno, Ignacio Pérez de Castro, Marta Gómez de
9
Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression María J. Bueno, Ignacio Pérez de Castro, Marta Gómez de Cedrón, Javier Santos, George A. Calin, Juan C. Cigudosa, Carlo M. Croce, José Fernández-Piqueras, Marcos Malumbres Cancer Cell Volume 13, Issue 6, Pages 496-506 (June 2008) DOI: 10.1016/j.ccr.2008.04.018 Copyright © 2008 Elsevier Inc. Terms and Conditions

Upload: lorin-henry

Post on 16-Dec-2015

217 views

Category:

Documents


1 download

Report

Tags:

TRANSCRIPT

Page 1: Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression María J. Bueno, Ignacio Pérez de Castro, Marta Gómez de

Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression 

María J. Bueno, Ignacio Pérez de Castro, Marta Gómez de Cedrón, Javier Santos, George A. Calin, Juan C. Cigudosa, Carlo M. Croce, José Fernández-Piqueras, Marcos Malumbres 

Cancer Cell Volume 13, Issue 6, Pages 496-506 (June 2008)

DOI: 10.1016/j.ccr.2008.04.018

Copyright © 2008 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions
Page 2: Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression María J. Bueno, Ignacio Pérez de Castro, Marta Gómez de

Figure 1

Cancer Cell 2008 13, 496-506DOI: (10.1016/j.ccr.2008.04.018) Copyright © 2008 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions
Page 3: Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression María J. Bueno, Ignacio Pérez de Castro, Marta Gómez de

Figure 2

Cancer Cell 2008 13, 496-506DOI: (10.1016/j.ccr.2008.04.018) Copyright © 2008 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions
Page 4: Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression María J. Bueno, Ignacio Pérez de Castro, Marta Gómez de

Figure 3

Cancer Cell 2008 13, 496-506DOI: (10.1016/j.ccr.2008.04.018) Copyright © 2008 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions
Page 5: Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression María J. Bueno, Ignacio Pérez de Castro, Marta Gómez de

Figure 4

Cancer Cell 2008 13, 496-506DOI: (10.1016/j.ccr.2008.04.018) Copyright © 2008 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions
Page 6: Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression María J. Bueno, Ignacio Pérez de Castro, Marta Gómez de

Figure 5

Cancer Cell 2008 13, 496-506DOI: (10.1016/j.ccr.2008.04.018) Copyright © 2008 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions
Page 7: Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression María J. Bueno, Ignacio Pérez de Castro, Marta Gómez de

Figure 6

Cancer Cell 2008 13, 496-506DOI: (10.1016/j.ccr.2008.04.018) Copyright © 2008 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions
Page 8: Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression María J. Bueno, Ignacio Pérez de Castro, Marta Gómez de

Figure 7

Cancer Cell 2008 13, 496-506DOI: (10.1016/j.ccr.2008.04.018) Copyright © 2008 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions
Page 9: Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression María J. Bueno, Ignacio Pérez de Castro, Marta Gómez de

Figure 8

Cancer Cell 2008 13, 496-506DOI: (10.1016/j.ccr.2008.04.018) Copyright © 2008 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions

From RSV Oncogene Src to YAP Oncogene of the Hippo Tumor ...€¦ · From RSV Oncogene Src to YAP Oncogene of the Hippo Tumor Suppressor Pathway 4th Singapore Sarcoma Meeting Academia,

Discovery and Roles of Virus-Encoded RNA Silencing …p6 of RRSV displays mild silencing suppressor activity and affects long-range silencing by delaying the systemic silencing signal

Oncogene, anti-oncogene and growth factor The biochemistry and molecular biology department of CMU

Novel treatment approaches in (pediatric) Therapy selected Selection of clones or genetic events that confer resistance ... NUP214-ABL1 transient response RANBP2-ABL1 ZMIZ1-ABL1 RCSD1-ABL1

BCR/ABL1 and BCR are under the transcriptional control of ... · RESEARCH Open Access BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene Nitesh Sharma1†,

RNA Silencing

Detection of mutations and gene fusions in pediatric ... Distinguish relapse or metastasis from second tumor ... ETV6-ABL1 NUP214-ABL1 RBM15-MKL1 ZEB2-PDGFRB ETV6-JAK2 NUP98-NSD1 RCSD1-ABL1

spiral.imperial.ac.uk · Web viewTHE PROPORTION OF DIFFERENT BCR-ABL1 TRANSCRIPT TYPES IN CHRONIC MYELOID LEUKEMIA. AN INTERNATIONAL OVERVIEW. Running title: BCR-ABL1 transcript type

The KRAS Oncogene

Oncogene Review

Gene Silencing Techniques

Clinical Appropriateness Guidelines Molecular Testing of ......81170 ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) (eg, acquired imatinib tyrosine kinase inhibitor resistance),

“Estudios Genéticos en Neoplasias Mieloproliferativas BCR-ABL1 · Las neoplasias mieloproliferativas BCR-ABL1 negativas (NMPs BCR-ABL1-) integran un grupo heterogéneo de patologías

Annurev.gene Silencing

FOXO Oncogene Brunet

BCR/ABL1 Quant (CE IVD): a Cost Effective Multiplex Assay · PDF fileBCR/ABL1 Quant (CE IVD): a Cost Effective Multiplex Assay for Quantitative/Qualitative Analysis of BCR/ABL1 Jane

Chapter 20 oncogene, anti-oncogene and growth factor The biochemistry and molecular biology department of CMU

Gene Silencing

OncoNext Tissue 50 γονίδια...OncoNext Tissue 50 γονίδια Page 2 of 107 ABL1 X16416 12608 c.730A>G p.M244V ABL1 X16416 12609 c.756G>C p.Q252H ABL1 X16416 12610 c.758A>T

ipsogen® BCR-ABL1 mbcr Kit Handbook

Case 0094 NUP214-ABL1 Fusion - sh-eahp.org SH PPT.pdfof part of the ABL1 and NUP214 genes. ... usually a late event, associated with early relapse Few cases of B-ALL ... NUP214-ABL1

BCR-ABL1 Compound Mutations Combining Key Kinase …

Oncogene etc

Research Article Oncogene-Mediated Progressive Silencing ...downloads.hindawi.com/journals/bmri/2015/780409.pdf · Research Article Ras Oncogene-Mediated Progressive Silencing of

Lecture 8 Oncogene and anti-oncogene Zhihong Li （李志红）

The proximal signaling network of the BCR-ABL1 … et al... · The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization B Titz, T Low, E Komisopoulou,

ABL1 Power Supply Brouchere

Transgene silencing

RNA silencing:

Oncogene Addiction versus Oncogene Amnesia: …...Perhaps the most compelling evidence that cancer can be reversed through oncogene inactivation came from studies performed using conditional

Súčasné možnosti liečby BCR‑ABL1 pozitívnej chronickej ... › pdfs › vnl › 2020 › 04 › 01.pdfPŘEHLEDOVÉ ČLÁNKY Súčasné možnosti liečby BCR‑ABL1 pozitívnej

Sure silencing

Dr. Pablo Mingote...Oncogene: mutación de un proto oncogene (sólo en células somáticas): Mutación puntual en el proto oncogene Amplificación (reduplicación) segmento ADN de

protein dockinng for ABL1 gene

oncogene as a transcription activator